ACTIVE

NEWPHARMA GROUP

Financial year 2025 · closed on 31/03/2025
Net result
-42,3 k €
+96.6% YoY
Revenue
7,8 M €
-6.9% YoY
Equity
86,7 M €
+8.7% YoY
Workforce
39,2 ETP
-6.4% YoY

What does NEWPHARMA GROUP do?

NEWPHARMA GROUP is a Public limited company incorporated in 2017. Its main activity is: Activities of head offices. Its registered office is in Liège. It employs on average 39,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0684.465.652
Incorporation
07/11/2017
Legal form
Public limited company
Registered office
Rue du Charbonnage 9
4020 Liège · WallonieSee on map
Contributed capital
86 745 274,00 €
Latest accounts
31/03/2025
Average workforce
39,2 ETP
Joint committees (1)
  • 200
Signals
Solid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420222021202020192018
Income statement
Revenue7,8 M €8,4 M €3,9 M €4,1 M €1,2 M €1,6 M €1,6 M €
EBITDA437,3 k €30 k €-1,4 M €-242,3 k €-1,8 M €-619,3 k €-139,1 k €
Operating result117,2 k €-599,1 k €-1,9 M €-383,9 k €-1,8 M €-619,3 k €-139,1 k €
Net result-42,3 k €-1,2 M €-2,4 M €-726,8 k €-2,1 M €-874,7 k €-418,3 k €
Balance sheet
Equity86,7 M €79,7 M €61 M €63,4 M €64,1 M €66,2 M €67,1 M €
Total assets101,1 M €99,2 M €96 M €88,3 M €87,2 M €83 M €82,1 M €
Cash1,2 k €36,7 k €8,6 k €84 k €2,3 M €137,7 k €71,3 k €
Debts14,1 M €19 M €34,5 M €24,6 M €22,9 M €16,7 M €15 M €
Other
Workforce39,2 ETP41,9 ETP39,6 ETP36,0 ETP30,4 ETP21,3 ETP10,7 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2025 · 6 active · 17 ended

Active mandates

JEF COLRUYT

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
JO WILLEMYNS

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
KRIS CASTELEIN

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
STEFAAN VANDAMME

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
STEFAN GOETHAERT

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
GJ LIFESCIENCES MANAGEMENT

Managing director · since 14 juillet 2021 · until 25 juin 2027 · 0770.962.631

Represented by GILLES JOURQUIN

Active

Ended mandates

JEF COLRUYT

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
JO WILLEMYNS

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
KRIS CASTELEIN

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
STEFAAN VANDAMME

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
At this address

Other companies at this address

CompanyCBE no.
1004.124.303
Annual accounts

Full financial information

202520242022202120202019
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/04/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/03/202531/03/202431/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months15 months12 months12 months12 months12 months
Filing date25/09/202519/09/202405/07/202306/07/202228/07/202114/08/2020
General meeting16/09/202517/09/202430/06/202330/06/202230/06/202130/07/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

10 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/03/202516/09/202525/09/2025FrenchPDF
Full model31/03/202417/09/202419/09/2024FrenchPDF
Full model31/12/202230/06/202305/07/2023FrenchPDF
Full model31/12/202130/06/202206/07/2022FrenchPDF
Consolidated accounts31/12/202130/06/202206/07/2022FrenchPDF
Full model31/12/202030/06/202128/07/2021FrenchPDF
Consolidated accounts31/12/202030/06/202126/07/2021FrenchPDF
Full model31/12/201930/07/202014/08/2020FrenchPDF
Consolidated accounts31/12/201930/07/202014/08/2020FrenchPDF
Full model31/12/201828/06/201925/07/2019FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 6 active · 17 ended

Active mandates

JEF COLRUYT

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
JO WILLEMYNS

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
KRIS CASTELEIN

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
STEFAAN VANDAMME

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
STEFAN GOETHAERT

Director · since 20 janvier 2023 · until 18 septembre 2028

Active
GJ LIFESCIENCES MANAGEMENT

Managing director · since 14 juillet 2021 · until 25 juin 2027 · 0770.962.631

Represented by GILLES JOURQUIN

Active

Ended mandates

JEF COLRUYT

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
JO WILLEMYNS

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
KRIS CASTELEIN

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
STEFAAN VANDAMME

Director · since 20 janvier 2023 · until 22 juin 2029

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office29/06/2026
    SIEGE SOCIAL
    PDF
  • Restructuring20/11/2025
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring04/09/2025
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Capital / shares04/04/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Other14/06/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates20/10/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares07/04/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates23/03/2023
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-42,3 k €
  2. 21/03/2025
    augmentation_capital
  3. 21/03/2025
    reduction_capital
  4. 2024
    Annual accounts 2024-1,2 M €
  5. 28/03/2023
    augmentation_capital
  6. 20/01/2023
    nominationJef Colruyt — administrateur
  7. 20/01/2023
    nominationStefaan Vandamme — administrateur
  8. 20/01/2023
    nominationJo Willemyns — administrateur
  9. 20/01/2023
    nominationStefan Goethaert — administrateur
  10. 20/01/2023
    nominationKris Castelein — administrateur
  11. 2022
    Annual accounts 2022-2,4 M €
  12. 2021
    Annual accounts 2021-726,8 k €
  13. 2020
    Annual accounts 2020-2,1 M €
  14. 2019
    Annual accounts 2019-874,7 k €
  15. 2018
    Annual accounts 2018-418,3 k €
  16. 07/11/2017
    IncorporationPublic limited company